Elbasvir/Grazoprevir (Zepatier)

elbasvir/grazoprevir · Merck & Co.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Elbasvir/Grazoprevir (Zepatier), covering 2017-04-12 to 2017-04-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Effect of Elbasvir/Grazoprevir Combination Therapy in Hemodialysis Patients With Chronic Hepatitis C [Phase 4]

See pricing